221
Views
13
CrossRef citations to date
0
Altmetric
LARYNX

The impact of comorbidity on the survival of patients with laryngeal squamous cell carcinoma

, , , , &
Pages 840-846 | Received 29 Dec 2010, Accepted 20 Jan 2011, Published online: 15 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shi Zhou, Xing-Hu Zhang, Yuan Zhang, Ge Gong, Xiang Yang & Wen-Hui Wan. (2022) The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients. Cancer Management and Research 14, pages 1683-1691.
Read now

Articles from other publishers (12)

Yuh-Seog Jung, Dahhay Lee, Kyu-Won Jung & Hyunsoon Cho. (2023) Long-term Survivorship and Non-cancer Competing Mortality in Head and Neck Cancer: A Nationwide Population-Based Study in South Korea. Cancer Research and Treatment 55:1, pages 50-60.
Crossref
Hiroji Shinkawa, Shogo Tanaka, Shigekazu Takemura, Ryosuke Amano, Kenjiro Kimura, Takayoshi Nishioka, Toru Miyazaki & Shoji Kubo. (2020) Predictive Value of the Age-Adjusted Charlson Comorbidity Index for Outcomes After Hepatic Resection of Hepatocellular Carcinoma. World Journal of Surgery 44:11, pages 3901-3914.
Crossref
Joshua B. Smith, Matthew Shew, Omar A. Karadaghy, Rohit Nallani, Kevin J. Sykes, Gregory N. Gan, Jason A. Brant & Andrés M. Bur. (2020) Predicting salvage laryngectomy in patients treated with primary nonsurgical therapy for laryngeal squamous cell carcinoma using machine learning. Head & Neck 42:9, pages 2330-2339.
Crossref
I. Zapata, M. Alvarez, R. Hidalgo, B. Pajares, M. J. Garcia-Anaya, M. D. Toledo, J. M. Trigo, Y. Lupiañez-Perez, J. A. Medina & J. Jaime Gomez-Millan. (2019) Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy. BMC Cancer 19:1.
Crossref
C.A. Righini & C. Colombe. 2019. Cancers du Larynx. Cancers du Larynx 47 53 .
Collin F. Mulcahy, Abdallah S. R. Mohamed, Aasheesh Kanwar, Katherine A. Hutcheson, Alokananda Ghosh, David Vock, Randal S. Weber, Stephen Y. Lai, Gary Brandon Gunn, Mark Zafereo, William H. Morrison, Renata Ferrarotto, Adam S. Garden, David I. Rosenthal & Clifton D. Fuller. (2018) Age‐adjusted comorbidity and survival in locally advanced laryngeal cancer. Head & Neck 40:9, pages 2060-2069.
Crossref
Jennifer R. Wang, Steven Habbous, Osvaldo Espin-Garcia, Duoduo Chen, Shao Hui Huang, Colleen Simpson, Wei Xu, Fei-Fei Liu, Dale H. Brown, Ralph W. Gilbert, Patrick J. Gullane, Jonathan C. Irish, David P. Goldstein & Geoffrey Liu. (2016) Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma. Head & Neck 38:5, pages 736-742.
Crossref
Steven Habbous, Luke T. G. Harland, Anthony La Delfa, Ehab Fadhel, Wei Xu, Fei-Fei Liu, David Goldstein, John Waldron, Shao-Hui Huang, Brian O'Sullivan & Geoffrey Liu. (2014) Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status. Head & Neck 36:6, pages 802-810.
Crossref
Charlotte Rotbøl Bøje, Susanne O. Dalton, Hanne Primdahl, Claus A. Kristensen, Elo Andersen, Jørgen Johansen, Lisbeth J. Andersen & Jens Overgaard. (2014) Evaluation of comorbidity in 9388 head and neck cancer patients: A national cohort study from the DAHANCA database. Radiotherapy and Oncology 110:1, pages 91-97.
Crossref
Charlotte Rotbøl Bøje. (2014) Impact of comorbidity on treatment outcome in head and neck squamous cell carcinoma – A systematic review. Radiotherapy and Oncology 110:1, pages 81-90.
Crossref
Steven Habbous, Karen P. Chu, Luke T.G. Harland, Anthony La Delfa, Ehab Fadhel, Bin Sun, Wei Xu, Amy Wong, Doris Howell, Jolie Ringash, John Waldron, Brian O’Sullivan, David Goldstein, Shao-Hui Huang & Geoffrey Liu. (2013) Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients. Oral Oncology 49:5, pages 407-412.
Crossref
Franziska Peter, Claus Wittekindt, Mira Finkensieper, Michael Kiehntopf & Orlando Guntinas-Lichius. (2012) Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients. Journal of Cancer Research and Clinical Oncology 139:1, pages 171-178.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.